Level C· Early human research exploring benefitsCase Report / SeriesPubMed

Is there a role for stem cells in treating articular injury?

Mirza YH., Oussedik S.

Case Report / Series on Osteoarthritis, Cartilage Damage, published in Br J Hosp Med (Lond) (2017) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
Br J Hosp Med (Lond) (2017)
Country
Singapore
Reported sample size
—
Source database
PubMed
PMID
28692374
DOI
10.12968/hmed.2017.78.7.372

Abstract (original English)

Articular cartilage is a specialized tissue with a high prevalence of injuries. The complex architecture of articular cartilage means that injuries are difficult to treat. The sequelae of such injuries include post-traumatic osteoarthritis. Current treatments include microfracture, microdrilling, osteochondral transplantation and matrix autologous chondral implantation. However, current surgical therapies have a number of disadvantages. Mesenchymal stem cells have been suggested as a potential alternative therapy, with a theoretical ability to regenerate articular cartilage. Research, although positive, is mainly limited to case series, in which the follow up is short to medium term. Stem cells may hold the answer to the age-old problem of articular cartilage injury but more robust evidence is required.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adipose TissueArthroscopyBone Marrow CellsBone TransplantationCartilage, ArticularChondrocytesFibrocartilageHip InjuriesHumansHyaline Cartilage

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research